Screener
Revolution Medicines, Inc. RVMD EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335104
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total non-operating income (expense), net | (139,239) | 16,927 | (147,833) | 44,271 |
| Loss before income taxes | (644,371) | (247,787) | (1,098,187) | (461,203) |
| Net loss | $(644,371) | $(247,787) | $(1,098,187) | $(461,203) |
| Net loss per share attributable to common stockholders, basic and diluted | $(3.06) | $(1.31) | (5.37) | $(2.45) |
| Weighted-average common shares used to compute net loss per share, basic and diluted | 210,893,604 | 188,583,288 | 204,531,173 | 188,365,805 |
| Comprehensive loss: | ||||
| Net loss | $(644,371) | $(247,787) | $(1,098,187) | $(461,203) |
| Other comprehensive loss: |
Item 1. Financial Statements.
FAQ
- What is Revolution Medicines, Inc.'s EPS (basic)?
- Revolution Medicines, Inc. (RVMD) reported EPS (basic) of -$3.06 in Q2 2026.
- How has Revolution Medicines, Inc.'s EPS (basic) changed year-over-year?
- Revolution Medicines, Inc.'s EPS (basic) decreased by 133.6% year-over-year, from -$1.31 to -$3.06.
- What is the long-term trend for Revolution Medicines, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s EPS (basic) has grown at a 23.3% compound annual growth rate (CAGR), from -$2.57 to -$5.94.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Revolution Medicines, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude